tirzepatide dual agonist is a first-in-class targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances glp-1 gip dual agonist GIP–GLP1-Receptor
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20

















.webp)








-1775582746855.png&w=3840&q=75)